SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Contingent Liabilities | ₹5.21 Cr | ₹4.97 Cr | - | - |
What is the latest Contingent Liabilities ratio of SHREE GANESH REMEDIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹5.21 Cr |
| Mar2024 | ₹4.97 Cr |
| Mar2020 | - |
| Mar2019 | - |
How is Contingent Liabilities of SHREE GANESH REMEDIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹5.21 Cr | 4.87 | |
| Mar2024 | ₹4.97 Cr | 0 | |
| Mar2020 | - | 0 | |
| Mar2019 | - | - | |
Compare Contingent Liabilities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹591.0 Cr | -7% | -9.9% | -41.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,738.0 Cr | 1.4% | 3.5% | -5.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,460.0 Cr | -3.9% | 6.6% | 15.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,476.0 Cr | 7% | 7.8% | 19.8% | Stock Analytics | |
| CIPLA | ₹122,361.0 Cr | 0.8% | 0.2% | -5.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,101.0 Cr | 0.9% | -2.8% | -5.8% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -7% |
-9.9% |
-41.2% |
| SENSEX | -0.1% |
2.6% |
6.5% |
You may also like the below Video Courses